Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MSN Laboratories Pvt. Ltd.

http://www.msnlabs.com

Latest From MSN Laboratories Pvt. Ltd.

Torrent Expects Indian Dapagliflozin Ruling In Q3

With the India business on the road to recovery and the US growth outlook muted, Torrent hopes to keep the boat steady in fiscal 2021. It also expects an order in Q3 in a patent infringement case pertaining to AstraZeneca’s Farxiga, where it and multiple Indian firms are seeking to launch generic versions.

Legal Issues Generic Drugs

Torrent Expects India Ruling On AZ's Farxiga In Q3

With the India business on the road to recovery and the US growth outlook muted, Torrent hopes to keep the boat steady in fiscal 2021. It also expects an order in Q3 in a patent infringement case pertaining to AstraZeneca’s Farxiga, where it and multiple Indian firms are seeking to launch generic versions.

Commercial Sales & Earnings

Lyrica Generics Were Likely Delayed By A Pfizer Labeling Supplement

US FDA's last-minute approval may have allowed Pfizer three more weeks of sales without competition.

Regulation Generic Drugs

Lyrica Generics Likely Delayed By A Pfizer Labeling Supplement

US FDA's last-minute approval may have allowed Pfizer three more weeks of sales without competition.

Neurology Generic Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
UsernamePublicRestriction

Register